Axsome Therapeutics, Inc.: Diferență între versiuni

1.386 de octeți adăugați ,  18 septembrie 2024
Pagină nouă: Pagina dedicata companiei Axsome Therapeutics, Inc. listata cu simbolul US.AXSM ==Descriere companie== Axsome Therapeutics, Inc. (www.axsome.com) is a biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders. The Company's core CNS portfolio includes five product candidates, which includes AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14. AXS-05 is an oral N-methyl-D-aspartate (NMDA) receptor antagonist...
(Pagină nouă: Pagina dedicata companiei Axsome Therapeutics, Inc. listata cu simbolul US.AXSM ==Descriere companie== Axsome Therapeutics, Inc. (www.axsome.com) is a biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders. The Company's core CNS portfolio includes five product candidates, which includes AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14. AXS-05 is an oral N-methyl-D-aspartate (NMDA) receptor antagonist...)
(Nicio diferență)